Endocrine and Metabolic Illnesses in Young Adults with Prader-Willi Syndrome

Eu-Seon Noh1, Min-Sun Kim1, Chiwoo Kim1

  • 1Department of Pediatrics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul 06351, Korea.

Insights

Young adults with Prader-Willi syndrome (PWS) face higher risks of metabolic and endocrine conditions like type 2 diabetes and obesity. Early screening and intervention are crucial for better health outcomes in PWS patients.

Area of Science:

  • Endocrinology
  • Genetics
  • Metabolic Disorders

Background:

  • Prader-Willi syndrome (PWS) is a rare genetic disorder causing insatiable appetite and obesity.
  • Previous research on PWS health issues focused on older adults, leaving a gap in understanding younger adult complications.
  • Endocrine and metabolic illnesses in young adults with PWS remain understudied.

Purpose of the Study:

  • To investigate the prevalence of endocrine and metabolic illnesses in young adults with PWS.
  • To compare these health issues with a matched healthy control group.
  • To assess the impact of recombinant human growth hormone (rhGH) treatment on obesity in adult PWS patients.

Main Methods:

  • Retrospective cohort study of 68 individuals with PWS (aged 19-34 years).
  • Comparison with an age-, sex-, and BMI-matched healthy control group.
  • Analysis of endocrine and metabolic conditions, including metabolic syndrome, type 2 diabetes, hypertension, dyslipidemia, bone density, and sleep apnea.

Main Results:

  • Young adults with PWS showed significantly higher rates of metabolic syndrome (35.3% vs. 4.4%), type 2 diabetes (50.0% vs. 5.4%), hypertension (30.8% vs. 16.1%), dyslipidemia (38.2% vs. 14.7%), decreased bone density (26.4% vs. 0.9%), and sleep apnea (32.3% vs. 4.4%).
  • Adult PWS patients on rhGH treatment had a lower likelihood of a BMI ≥ 30 (OR = 0.106).
  • These conditions may manifest in early adolescence.

Conclusions:

  • Young adults with PWS have a high burden of endocrine and metabolic comorbidities.
  • Continuous rhGH treatment may help manage obesity in adulthood.
  • Early screening and intervention are essential for managing PWS complications and improving long-term health.

Related Concept Videos

Adrenal Gland Disorders01:27

Adrenal Gland Disorders

Adrenal gland disorders manifest when the production of adrenal hormones deviates from the norm, resulting in either excessive or insufficient concentrations.
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
1.8K
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
237
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
681
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.2K
Major Hormones and Their Functions01:27

Major Hormones and Their Functions

Hormones, the biochemical messengers produced by endocrine glands, are pivotal in regulating bodily functions and maintaining homeostasis. Each hormone's balance is crucial; imbalances can lead to significant physiological disruptions. Major hormones include oxytocin, cortisol, epinephrine, estrogen, testosterone, thyroxine, growth hormone, insulin, and glucagon.
Oxytocin, produced in the hypothalamus and released by the pituitary gland, plays a role in social bonding, childbirth, and...
668